A team of Geisel researchers will receive funding from the Patient-Centered Outcomes Research Institute (PCORI) to design new methods for comparing the effectiveness of alternative therapies that can lead to improvements in practice and better outcomes for patients.
Geisel researchers take a close look at New Hampshire’s complex opioid epidemic, and one city’s novel response.
Dartmouth-led research is in early phase drug discovery and finds promising therapeutic leads after targeting vulnerabilities in nervous system tumors, including glioblastoma.
Dartmouth SYNERGY Scholars prepares young clinical scientists for success in today’s highly competitive research environment.
More than $12 million over five years has been awarded for research collaboration to more precisely determine lung cancer risk and improve screening.
Physician Amber Barnato, acclaimed for her research on physician decision-making for patients with serious illnesses, has been named the inaugural Susan J. and Richard M. Levy 1960 Distinguished Professor in Health Care Delivery. She begins work in Hanover on July 1.
A new study by researchers at Dartmouth has found that adolescents living in medical marijuana states with a plethora of dispensaries are more likely to have tried new methods of cannabis use, such as edibles and vaping, at a younger age than those living in states with fewer dispensaries.
Large study co-led by Geisel professor Christopher Amos, PhD, identified several new variants for lung cancer risk that will translate into improved understanding of the mechanisms involved in lung cancer risk.
Carrie Colla, an associate professor at The Dartmouth Institute for Health Policy and Clinical Practice, has been chosen to participate in the 2017-2018 Robert Wood Johnson Foundation Health Policy Fellows program.
Charles Barlowe, PhD, chair and professor of biochemistry and cell biology at the Geisel School of Medicine, has been named the James C. Chilcott 1920 Professor.